Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ollila

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
The Oncologist|May 19, 2020
Navigating Roadblocks as an Early Career Attending … LiterallyThomas A Ollila
Leukemia & Lymphoma|July 4, 2018
Radiation therapy in primary testicular lymphoma: does practice match the standard of care?Thomas A Ollila, Adam J Olszewski
Blood|March 30, 2019
Acanthocytosis causing chronic hemolysis in a patient with advanced cirrhosisEric I Marks, Thomas A Ollila
Cancer Management and Research|May 21, 2021
Chemotherapy-Free Management of Follicular and Marginal Zone LymphomaThomas A Ollila, Adam J Olszewski
Current Treatment Options in Oncology|June 23, 2018
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System RecurrenceThomas A Ollila, Adam J Olszewski
Oncotarget|September 22, 2023
Reassessing the risks and benefits of COVID-19 precautions in 2023Thomas A Ollila, Rashida Taher, Prashanth Moku
Cancer Management and Research|September 13, 2023
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell LymphomaAri Pelcovits, Thomas A Ollila, Adam J Olszewski
Leukemia|March 24, 2020
Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based studyMengyang Di, Thomas A Ollila, Adam J Olszewski
Oncotargets and Therapy|February 26, 2019
Mogamulizumab: a new tool for management of cutaneous T-cell lymphomaThomas A Ollila, Ilyas Sahin, Adam J Olszewski
Frontiers in Oncology|May 3, 2024
Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospectsCharles J Milrod, Ari Pelcovits, Thomas A Ollila
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
The Oncologist|May 19, 2020
Navigating Roadblocks as an Early Career Attending … LiterallyThomas A Ollila
Leukemia & Lymphoma|July 4, 2018
Radiation therapy in primary testicular lymphoma: does practice match the standard of care?Thomas A Ollila, Adam J Olszewski
Blood|March 30, 2019
Acanthocytosis causing chronic hemolysis in a patient with advanced cirrhosisEric I Marks, Thomas A Ollila
Cancer Management and Research|May 21, 2021
Chemotherapy-Free Management of Follicular and Marginal Zone LymphomaThomas A Ollila, Adam J Olszewski
Current Treatment Options in Oncology|June 23, 2018
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System RecurrenceThomas A Ollila, Adam J Olszewski
Oncotarget|September 22, 2023
Reassessing the risks and benefits of COVID-19 precautions in 2023Thomas A Ollila, Rashida Taher, Prashanth Moku
Cancer Management and Research|September 13, 2023
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell LymphomaAri Pelcovits, Thomas A Ollila, Adam J Olszewski
Leukemia|March 24, 2020
Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based studyMengyang Di, Thomas A Ollila, Adam J Olszewski
Oncotargets and Therapy|February 26, 2019
Mogamulizumab: a new tool for management of cutaneous T-cell lymphomaThomas A Ollila, Ilyas Sahin, Adam J Olszewski
Frontiers in Oncology|May 3, 2024
Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospectsCharles J Milrod, Ari Pelcovits, Thomas A Ollila
Pageof 5